Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

NCDL vs CCAP: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

NCDL Captures Overall Composite Edge (29.1 SELL vs 19.6 STRONG SELL), While CCAP Leads 3–1 on Growth & Valuation Pillars

NCDL Overall Winner 6-Pillar Tally: NCDL 1 – 3 CCAP (2 Tie) Matrix Metrics: NCDL 7 – 3 CCAP

As of Nov 16, 2026, Nuveen Churchill Direct Lending Corp (NCDL) captures the overall head-to-head institutional edge over Crescent Capital BDC, Inc. (CCAP) on higher Unified Composite conviction (29.1/100 SELL vs. 19.6/100 STRONG SELL) after splitting the core matrix 7–3 (led by Growth & Scale), while CCAP wins 3–1 across the 6-pillar growth and valuation breakdown. NCDL trades at $11.64 (7.3x Forward P/E, 0.0% operating margin) versus CCAP at $10.08 (6.9x Forward P/E, 78.4% operating margin).

  • Growth vs. Quality Trade-Off: NCDL earns the overall head-to-head edge with a stronger Unified Composite Score (29.1/100 SELL vs. CCAP 19.6/100 STRONG SELL) and 0.47β · 26% Vol risk profile, whereas CCAP leads top-line expansion (-15.5% YoY revenue growth, 0.89x PEG, and 3 of 6 institutional pillars) for higher-beta growth mandates.
  • Defensive Composite Rating Caution: Although NCDL compares more favorably head-to-head, both NCDL (29.1/100 SELL) and CCAP (19.6/100 STRONG SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About NCDL vs CCAP
NCDL NYSE Head-to-Head Winner
Nuveen Churchill Direct Lending Corp
Institutional Equity
$11.64
-1.27% 1D
Market Cap $579.0M
TTM Revenue N/A
Forward P/E 7.3x
Beta / 30D Vol 0.47β · 26% Vol
Unified Composite Score
29.1 / 100 SELL
Tech 13.0 Fund 35.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 55
RSI-14: 54.8 · SMA20: $11.33 · SMA50: $11.41
CCAP NASDAQ
Crescent Capital BDC, Inc. Common stock
Institutional Equity
$10.08
-0.49% 1D
Market Cap $373.2M
TTM Revenue $156M
Forward P/E 6.9x
Beta / 30D Vol 0.44β · 50% Vol
Unified Composite Score
19.6 / 100 STRONG SELL
Tech 50.0 Fund 28.0 Flow 50.0 Mom 40.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 61
RSI-14: 61.3 · SMA20: $9.36 · SMA50: $9.42

6-Pillar Scorecard Institutional Category Breakdown (NCDL 1 – 3 CCAP)

Columns: Metric · NCDL · CCAP
1. Valuation Multiples CCAP
Forward P/E 7.3x 6.9x
Trailing P/E 13.2x 7.4x
PEG Ratio N/M 0.89x
EV / Revenue N/M 2.4x
2. Growth & Scale NCDL
Revenue Growth (YoY) +0.0% -15.5%
Earnings Growth (YoY) +0.0% -14.9%
TTM Revenue (USD) N/A $156M
Market Cap $579.0M $373.2M
3. Profitability & Quality CCAP
Gross Margin N/A 100.0%
Operating Margin 0.0% 78.4%
Net Profit Margin 0.0% -2.0%
Return on Equity (ROE) 0.0% -0.5%
4. Balance Sheet & Cash Flow Tie
Cash Generation (TTM) N/A N/A
Cash Flow Margin N/A N/A
Net Cash / Leverage 0.0% ROE $19.10 Book/Sh · -0.5% ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Neutral NEUTRAL · Neutral
6. R&D & Supply-Chain Moat CCAP
OpEx & R&D Intensity N/A 21.6% of Rev ($34M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning High-Margin Pricing Power Moat
Supply-Chain Role Asset Management Operator Asset Management Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: NCDL (7) vs CCAP (3)
Institutional Metric NCDL CCAP Criterion Row Edge
Market Capitalization
Scale
$579.0M $373.2M Larger Scale NCDL
Trailing P/E Ratio
Valuation
13.2x 7.4x Lower Multiple CCAP
Forward P/E Ratio
Valuation
7.3x 6.9x Lower Multiple CCAP
Revenue Growth (YoY)
Growth
+0.0% -15.5% Higher Growth NCDL
Operating Margin (TTM)
Profitability
0.0% 78.4% Higher Margin CCAP
Net Profit Margin
Profitability
0.0% -2.0% Higher Margin NCDL
Return on Equity (ROE)
Capital Efficiency
0.0% -0.5% Higher ROE NCDL
52-Week Range Position
Momentum
28% ($10–$15) 25% ($8–$15) Stronger Trend NCDL
Beta / 30D Volatility
Risk Regime
0.47β · 26% Vol 0.44β · 50% Vol Lower Realized Risk NCDL
Unified Institutional Score
Composite Signal
29.1 / 100 (SELL) 19.6 / 100 (STRONG SELL) Higher Composite NCDL
Trailing 12M Revenue (USD)
Operating Scale
N/A $156M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A 100.0% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev 0.89x PEG · 2.4x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A (0.0% ROE) N/A ($19.10 Book/Sh · -0.5% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon CCAP +3.66 pp
NCDL: +9.6% · CCAP: +13.26%
3M Horizon NCDL +1.47 pp
NCDL: -5.37% · CCAP: -6.84%
6M Horizon CCAP +0.81 pp
NCDL: -9.84% · CCAP: -9.03%
1Y Horizon NCDL +6.22 pp
NCDL: -19.61% · CCAP: -25.83%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on NCDL vs CCAP. Trailing 12-month operating profitability (NCDL 0.0% vs CCAP 78.4%) and valuation multiples (NCDL 7.3x vs CCAP 6.9x Forward P/E) are benchmarked directly in Pillar 4 below.

NCDL ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. Margin0.0%
ROE / Fwd P/E0.0% · 7.3x
CCAP ADR TTM Benchmark FX-Normalized USD
TTM Revenue$156M
Gross Margin100.0%
Op. Margin78.4%
ROE / Fwd P/E-0.5% · 6.9x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
NCDL UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact NCDL Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
CCAP UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact CCAP Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
NCDL Moat Profile Cyclical / Execution-Driven Positioning
Asset Management Operator
Competes within the Asset Management value chain with $579.0M market capitalization and 0.0% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
CCAP Moat Profile High-Margin Pricing Power Moat
Asset Management Operator
Competes within the Asset Management value chain with $373.2M market capitalization and 78.4% operating margin.
OpEx & R&D Reinvestment 21.6% of Rev ($34M)
90D Engineering Disclosures 0 Published

Investor FAQ NCDL vs CCAP Key Questions & Quantitative Answers

As of Nov 16, 2026, Nuveen Churchill Direct Lending Corp (NCDL) captures the overall head-to-head institutional edge over Crescent Capital BDC, Inc. (CCAP) on higher Unified Composite conviction (29.1/100 SELL vs. 19.6/100 STRONG SELL) after splitting the core matrix 7–3 (led by Growth & Scale), while CCAP wins 3–1 across the 6-pillar growth and valuation breakdown. NCDL trades at $11.64 (7.3x Forward P/E, 0.0% operating margin) versus CCAP at $10.08 (6.9x Forward P/E, 78.4% operating margin). Growth vs. Quality Trade-Off: NCDL earns the overall head-to-head edge with a stronger Unified Composite Score (29.1/100 SELL vs. CCAP 19.6/100 STRONG SELL) and 0.47β · 26% Vol risk profile, whereas CCAP leads top-line expansion (-15.5% YoY revenue growth, 0.89x PEG, and 3 of 6 institutional pillars) for higher-beta growth mandates. Defensive Composite Rating Caution: Although NCDL compares more favorably head-to-head, both NCDL (29.1/100 SELL) and CCAP (19.6/100 STRONG SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.

NCDL leads the Growth & Scale pillar: NCDL posts +0.0% YoY revenue growth and +0.0% YoY earnings growth on N/A TTM revenue (N/A gross margin, 0.0% operating margin), compared with CCAP at -15.5% YoY revenue growth and -14.9% YoY earnings growth on $156M TTM revenue (100.0% gross margin, 78.4% operating margin). On trailing 12-month operating scale, NCDL generates N/A in USD-normalized revenue versus $156M for CCAP. In operating R&D and SG&A reinvestment, NCDL deploys N/A (0 90-day corporate R&D disclosures) versus 21.6% of Rev ($34M) (0 disclosures) for CCAP.

CCAP screens cheaper on headline valuation multiples. NCDL trades at 7.3x Forward P/E, 13.2x Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas CCAP trades at 6.9x Forward P/E, 7.4x Trailing P/E, 0.89x PEG, and 2.4x EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against NCDL (0.0% ROE) versus CCAP (-0.5% ROE) capital efficiency.

In options market volatility and institutional positioning, NCDL carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.47β · 26% Vol realized risk). By comparison, CCAP carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.44β · 50% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.